Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis

Neil M. Ampel, Daniel K. Nelson, Suzette Chavez, Kathryn A. Naus, Amanda B. Herman, Lijin Li, Keira A. Simmons, Demosthenes Pappagianis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Assessment of the cellular immune response in coccidioidomycosis has epidemiologic and prognostic importance. Measurement of delayed-type hypersensitivity to skin testing has been used in the past to determine cellular immunity in coccidioidomycosis. However, no skin tests are currently available in the United States. Assay of gamma interferon (IFN-γ) release in whole blood in response to incubation with antigen has been used to assess cellular immunity in tuberculosis. We used a similar assay using the coccidioidal antigen preparation T27K to measure the in vitro cellular immune responses among a cohort of 69 subjects with active coccidioidomycosis. IFN-γ release was bimodal, with concentrations above and below 5 IU/ml. Using multivariate logistic regression, underlying disease and disseminated or chronic pulmonary coccidioidomycosis was significantly associated with the release of IFN-γ at a concentration of <5 IU/ml (P = 0.02 or 0.05, respectively). In addition, the release IFN-γ concentration was <5 IU/ml in all subjects with a clinical severity score of ≥6 (P = 0.02). The release IFN-γ concentration correlated with expression of CD69 on T lymphocytes in an in vitro assay using T27K as the antigen (Spearman's rho = 0.59; P < 0.01). These results suggest that the IFN-γ release assay with T27K as the antigen may be a useful clinical test for assessing cellular immunity in patients with active coccidioidomycosis.

Original languageEnglish (US)
Pages (from-to)700-704
Number of pages5
JournalClinical and Diagnostic Laboratory Immunology
Volume12
Issue number6
DOIs
StatePublished - Jun 2005

Fingerprint

Coccidioidomycosis
Cellular Immunity
Interferons
Interferon-gamma
Blood
Assays
Antigens
Skin
Interferon-gamma Release Tests
T-cells
Delayed Hypersensitivity
Skin Tests
Logistics
Tuberculosis
Logistic Models
T-Lymphocytes
Lung
Testing

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Clinical Biochemistry
  • Immunology

Cite this

Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis. / Ampel, Neil M.; Nelson, Daniel K.; Chavez, Suzette; Naus, Kathryn A.; Herman, Amanda B.; Li, Lijin; Simmons, Keira A.; Pappagianis, Demosthenes.

In: Clinical and Diagnostic Laboratory Immunology, Vol. 12, No. 6, 06.2005, p. 700-704.

Research output: Contribution to journalArticle

Ampel, Neil M. ; Nelson, Daniel K. ; Chavez, Suzette ; Naus, Kathryn A. ; Herman, Amanda B. ; Li, Lijin ; Simmons, Keira A. ; Pappagianis, Demosthenes. / Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis. In: Clinical and Diagnostic Laboratory Immunology. 2005 ; Vol. 12, No. 6. pp. 700-704.
@article{0bcce4cd6b994374bccfea0115f86513,
title = "Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis",
abstract = "Assessment of the cellular immune response in coccidioidomycosis has epidemiologic and prognostic importance. Measurement of delayed-type hypersensitivity to skin testing has been used in the past to determine cellular immunity in coccidioidomycosis. However, no skin tests are currently available in the United States. Assay of gamma interferon (IFN-γ) release in whole blood in response to incubation with antigen has been used to assess cellular immunity in tuberculosis. We used a similar assay using the coccidioidal antigen preparation T27K to measure the in vitro cellular immune responses among a cohort of 69 subjects with active coccidioidomycosis. IFN-γ release was bimodal, with concentrations above and below 5 IU/ml. Using multivariate logistic regression, underlying disease and disseminated or chronic pulmonary coccidioidomycosis was significantly associated with the release of IFN-γ at a concentration of <5 IU/ml (P = 0.02 or 0.05, respectively). In addition, the release IFN-γ concentration was <5 IU/ml in all subjects with a clinical severity score of ≥6 (P = 0.02). The release IFN-γ concentration correlated with expression of CD69 on T lymphocytes in an in vitro assay using T27K as the antigen (Spearman's rho = 0.59; P < 0.01). These results suggest that the IFN-γ release assay with T27K as the antigen may be a useful clinical test for assessing cellular immunity in patients with active coccidioidomycosis.",
author = "Ampel, {Neil M.} and Nelson, {Daniel K.} and Suzette Chavez and Naus, {Kathryn A.} and Herman, {Amanda B.} and Lijin Li and Simmons, {Keira A.} and Demosthenes Pappagianis",
year = "2005",
month = "6",
doi = "10.1128/CDLI.12.6.700-704.2005",
language = "English (US)",
volume = "12",
pages = "700--704",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis

AU - Ampel, Neil M.

AU - Nelson, Daniel K.

AU - Chavez, Suzette

AU - Naus, Kathryn A.

AU - Herman, Amanda B.

AU - Li, Lijin

AU - Simmons, Keira A.

AU - Pappagianis, Demosthenes

PY - 2005/6

Y1 - 2005/6

N2 - Assessment of the cellular immune response in coccidioidomycosis has epidemiologic and prognostic importance. Measurement of delayed-type hypersensitivity to skin testing has been used in the past to determine cellular immunity in coccidioidomycosis. However, no skin tests are currently available in the United States. Assay of gamma interferon (IFN-γ) release in whole blood in response to incubation with antigen has been used to assess cellular immunity in tuberculosis. We used a similar assay using the coccidioidal antigen preparation T27K to measure the in vitro cellular immune responses among a cohort of 69 subjects with active coccidioidomycosis. IFN-γ release was bimodal, with concentrations above and below 5 IU/ml. Using multivariate logistic regression, underlying disease and disseminated or chronic pulmonary coccidioidomycosis was significantly associated with the release of IFN-γ at a concentration of <5 IU/ml (P = 0.02 or 0.05, respectively). In addition, the release IFN-γ concentration was <5 IU/ml in all subjects with a clinical severity score of ≥6 (P = 0.02). The release IFN-γ concentration correlated with expression of CD69 on T lymphocytes in an in vitro assay using T27K as the antigen (Spearman's rho = 0.59; P < 0.01). These results suggest that the IFN-γ release assay with T27K as the antigen may be a useful clinical test for assessing cellular immunity in patients with active coccidioidomycosis.

AB - Assessment of the cellular immune response in coccidioidomycosis has epidemiologic and prognostic importance. Measurement of delayed-type hypersensitivity to skin testing has been used in the past to determine cellular immunity in coccidioidomycosis. However, no skin tests are currently available in the United States. Assay of gamma interferon (IFN-γ) release in whole blood in response to incubation with antigen has been used to assess cellular immunity in tuberculosis. We used a similar assay using the coccidioidal antigen preparation T27K to measure the in vitro cellular immune responses among a cohort of 69 subjects with active coccidioidomycosis. IFN-γ release was bimodal, with concentrations above and below 5 IU/ml. Using multivariate logistic regression, underlying disease and disseminated or chronic pulmonary coccidioidomycosis was significantly associated with the release of IFN-γ at a concentration of <5 IU/ml (P = 0.02 or 0.05, respectively). In addition, the release IFN-γ concentration was <5 IU/ml in all subjects with a clinical severity score of ≥6 (P = 0.02). The release IFN-γ concentration correlated with expression of CD69 on T lymphocytes in an in vitro assay using T27K as the antigen (Spearman's rho = 0.59; P < 0.01). These results suggest that the IFN-γ release assay with T27K as the antigen may be a useful clinical test for assessing cellular immunity in patients with active coccidioidomycosis.

UR - http://www.scopus.com/inward/record.url?scp=23844470568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844470568&partnerID=8YFLogxK

U2 - 10.1128/CDLI.12.6.700-704.2005

DO - 10.1128/CDLI.12.6.700-704.2005

M3 - Article

C2 - 15939743

AN - SCOPUS:23844470568

VL - 12

SP - 700

EP - 704

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 6

ER -